Please do not adjust margins
Dalton Transactions
Page 8 of 10
ARTICLE
N-(2,6-Dimethylphenyl)-1,1-diphenyl-1-(6-phenylpyridin-2-
Journal Name
3.1 mmol) was added and the mixture was stirred at 80 oC in the
yl)silanamine (6). General procedure B was applied using (2- dark for 12 h. After that, the mixture DwOaI:s10f.i1lt0e3r9e/Dd0DthT0ro10u3g1hF
chlorodiphenylsilyl)-6-phenylpyridine (1.86 g, 5.0 mmol) and Celite® and the volatiles were removed. The residue was
lithium 2,6-diisopropylanilide (0.64 g, 5.0 mmol). Yield: 1.94 g triturated with hexane, filtered off and dried in vacuum. This
(85%) were isolated. 1H NMR (CDCl3, 400 MHz): δ 8.15 (m, 2H), gave a pyridylamido hafnium dichloride complex of appropriate
7.80 (m, 4H), 7.73 (m, 1H), 7.64 (t, J = 7.7 Hz, 1H), 7.37–7.56 (m, purity which was then methylated without any additional
10H), 6.95 (d, J = 7.4 Hz, 2H), 6.76 (m, 1H), 5.27 (s, 1H), 2.25 (s, purification. Pyridylamido hafnium dimethyl complexes. A 3.0 M
6H). 13C NMR (CDCl3, 100 MHz): δ 164.3, 156.8, 143.6, 139.6, solution of MeMgBr in diethyl ether (2.5 mL, 7.5 mmol) was
135.5, 135.19, 135.15, 129.8, 129.2, 128.9, 128.6, 128.54, added to a solution of pyridylamido hafnium dichloride complex
128.48, 127.8, 127.0, 120.2, 120.1, 20.8. HRMS (APPI) m/z calcd (1.5 mmol) in toluene (50 mL). The mixture was then stirred for
o
for C31H29N2Si [M+H]+: 457.2095; found: 457.2094.
3 h at 70 C. After that, the volatiles were removed under
General procedure C for preparation of complexes 7–9. To a reduced pressure, and the residue was extracted with boiling
solution of pro-ligand 1–3 (2.3 mmol) in benzene (50 mL) solid hexane (3×30 mL). The volatiles were removed under reduced
tetrabenzylhafnium (1.25 g, 2.3 mmol) was added and the pressure, and the residue was washed with cold pentane and
o
mixture was stirred overnight at 80 C in the dark. After that, dried in vaccum to give a crude product as a white powdery
the mixture was filtered through Celite® and the volatiles were solid. Recrystallization of the crude product from toluene-
removed. Crystallization of the solid residue from toluene- hexane mixture afforded the pure dimethylated complex.
hexane mixture afforded the product as an orange crystalline Complex 10. General procedure D was applied using 4 (1.29 g,
solid.
3.1 mmol). Yield: 1.40 g (68%) of pyridylamido hafnium
Complex 7. General procedure C was applied using 1 (0.894 g, dichloride as a brown powder. 1H NMR (CDCl3, 400 MHz): δ 8.23
2.3 mmol). Yield: 963 mg (56%) were isolated. Сalcd for (m, 1H), 7.93–7.98 (m, 2H), 7.83 (m, 1H), 7.58 (dd, J = 6.4, 2.0
C39H44HfN2Si: C, 62.68; H, 5.93; N, 3.75; found: C, 62.75; H, 6.01; Hz, 2H), 7.34–7.39 (m, 2H), 7.08–7.16 (m, 3H), 3.41 (m, 2H), 1.29
N, 3.68. 1H NMR (CDCl3, 400 MHz): δ 7.77–7.84 (m, 2H), 7.71 (d, (d, J = 6.7 Hz, 6H), 1.19 (d, J = 6.9 Hz, 6H), 1.00–1.09 (m, 2H),
1H), 7.62 (d, J = 7.5 Hz, 1H), 7.45 (m, 2H), 7.14-7.27 (m, 4H), 0.89-0.93 (m, 8H). 13C NMR (CDCl3, 100 MHz): δ 199.5, 168.5,
7.05–7.09 (m, 1H), 6.87 (t, J = 7.6 Hz, 4H), 6.66 (t, J = 7.4 Hz, 2H), 164.1, 145.4, 143.9, 143.5, 143.4, 140.0, 130.7, 129.8, 128.4,
6.39 (d, J = 7.3 Hz, 4H), 3.44 (m, 2H), 2.11 (d, J = 11.6 Hz, 2H) 124.5, 123.8, 123.1, 119.0, 28.2, 26.1, 24.1, 7.5, 6.2. Yield of 10
1.79 (d, J = 11.7 Hz, 2H), 1.17 (d, J = 6.9 Hz, 6H), 1.09 (d, J = 6.9 on methylation step: 383 mg (41%) as a white solid. Сalcd for
Hz, 6H), 0.31 (s, 6H). 13C NMR (CDCl3, 100 MHz): δ 201.2, 170.3, C29H40HfN2Si: C, 55.89; H, 6.47; N, 4.49; found: C, 56.02; H, 6.64;
164.0, 146.0, 144.7, 144.0, 143.8, 139.4, 129.7, 129.0, 128.2, N, 4.21. 1H NMR (CDCl3, 400 MHz): δ 8.15 (m, 1H), 7.87–7.92 (m,
127.8, 127.1, 126.6, 124.1, 123.4, 123.0, 122.0, 118.4, 86.6, 2H), 7.83 (d, J = 7.8 Hz, 1H), 7.52 (dd, J1 = 5.6 Hz, J2 = 2.8 Hz, 1H),
28.5, 25.3, 25.0, 0.9.
7.42 (m, 1H), 7.33 (m, 1H), 7.10–7.13 (m, 2H), 7.03–7.07 (m, 1H),
Complex 8. General procedure C was applied using 2 (1.01 g, 2.3 3.55 (m, 2H), 1.19 (d, J = 6.8 Hz, 6H), 1.17 (d, J = 6.8 Hz, 6H),
mmol). Yield: 880 mg (48%) were isolated. Сalcd for 0.87–0.93 (m, 10H), 0.28 (s, 6H). 13C NMR (CDCl3, 100 MHz): δ
C43H46HfN2Si: C, 64.77; H, 5.81; N, 3.51; found: C, 64.92; H, 6.06; 202.2, 169.8, 165.1, 146.4, 144.5, 142.0, 139.8, 139.0, 130.1,
N, 3.40. 1H NMR (CDCl3, 400 MHz) δ 8.35 (d, J = 8.43, 1H), 8.06 128.4, 128.1, 123.7, 123.5, 122.9, 118.3, 64.3, 27.9, 25.8, 24.4,
(d, J = 8.2 Hz, 1H), 7.82–7.93 (m, 3H), 7.66 (d, J = 7.8 Hz, 1H), 7.6, 7.4.
7.42–7.52 (m, 3H), 7.18–7.20 (m, 2H), 7.09–7.13 (m, 1H), 6.86 Complex 11. General procedure D was applied using 5 (1.59 g,
(m, 4H), 6.63 (m, 2H), 6.42 (m, 4H), 3.56 (m, 2H), 2.18 (d, J = 11.9 3.1 mmol). Yield: 1.34 g (57%) of pyridylamido hafnium
1
Hz, 2H) 1.96 (d, J = 11.9 Hz, 2H), 1.18 (d, J = 6.9 Hz, 6H), 1.15 (d, dichloride as a brown powder. H NMR (CD2Cl2, 400 MHz): δ
J = 6.9 Hz, 6H), 0.38 (s, 6H). 13C NMR (CDCl3, 100 MHz): δ 204.2, 8.21 (m, 1H), 8.09–8.11 (m, 2H), 7.96 (m, 1H), 7.63 (dd, J = 6.5,
170.8, 164.9, 144.5, 144.0, 143.9, 143.4, 138.8, 135.4, 134.6, 2.2 Hz, 1H), 7.43 (m, 8H), 7.29 (m, 4H), 7.08–7.12 (m, 1H), 7.03
129.8, 129.0, 128.1, 127.1, 126.2, 126.1, 125.1, 124.1, 124.1, (s, 1H), 7.01 (d, J = 1.4 Hz, 1H) 3.18 (m, 2H), 1.16 (d, J = 6.9 Hz,
123.5, 123.3, 122.0, 87.7, 28.4, 25.3, 25.1, 0.9.
6H), 0.25 (d, J = 6.7 Hz, 6H). 13C NMR (CD2Cl2, 100 MHz): δ 199.7,
Complex 9. General procedure C was applied using 3 (0.954 g, 166.5, 164.6, 146.0, 145.0, 143.6, 141.3, 136.3, 135.6, 133.6,
2.3 mmol). Yield: 783 mg (44%) were isolated. Сalcd for 131.3, 130.8, 130.7, 130.4, 128.6, 128.3, 124.4, 123.8, 120.1,
C41H46HfN2Si: C, 63.67; H, 6.00; N, 3.62; found: C, 63.85; H, 6.18; 29.0, 26.5, 23.0. Yield of complex 11 on methylation step: 367
1
N, 3.48. H NMR (CDCl3, 400 MHz): δ 7.73–7.82 (m, 4H), 7.15– mg (34%) as a white solid. Сalcd for C37H40HfN2Si: C, 61.78; H,
7.36 (m, 6H), 6.92 (t, J = 7.6 Hz, 4H), 6.68 (t, J = 7.4 Hz, 2H), 6.56 5.61; N, 3.89; found: C, 61.99; H, 5.87; N, 3.72. 1H NMR (CDCl3,
(d, J = 7.2 Hz, 4H), 3.54 (m, 2H), 2.40 (d, J = 11.8 Hz, 2H) 2.10 (d, 400 MHz): δ 8.21 (m, 1H), 7.88–8.02 (m, 3H), 7.58 (m, 1H), 7.34–
J = 11.8 Hz, 2H), 1.68 (m, 4H), 1.25 (d, J = 6.8 Hz, 6H), 1.21 (d, J 7.42 (m, 8H), 7.25–7.30 (m, 4H), 8.98–7.07 (m, 3H), 3.33 (m, 2H),
= 6.8 Hz, 6H), 0.70-0.89 (m, 4H). 13C NMR (CDCl3, 100 MHz): δ 1.08 (d, J = 6.9 Hz, 6H), 0.41 (s, 6H), 0.32 (d, J = 6.9 Hz, 6H). 13C
201.8, 170.5, 164.1, 146.1, 144.0, 143.3, 139.7, 139.0, 129.8, NMR (CDCl3, 100 MHz): δ 202.0, 167.1, 165.0, 146.4, 145.4,
129.0, 128.2, 128.1, 127.9, 127.4, 126.7, 125.3, 124.2, 123.7, 140.0, 139.7, 139.4, 136.4, 135.7, 135.4, 135.1, 134.9, 130.3,
122.8, 122.1, 118.4, 89.1, 28.3, 26.6, 25.4, 24.9, 13.4.
130.1, 129.7, 128.5, 127.8, 125.4, 124.1, 123.8, 123.6, 123.0,
General procedure D for preparation of complexes 10–12. 118.8, 65.6, 64.6, 64.3, 34.7, 28.3, 27.8, 25.7, 25.5, 23.9, 23.4,
Pyridylamido hafnium dichlorides. To a solution of pro-ligand 4– 22.2, 14.2.
6 (3.1 mmol) in benzene (60 mL) solid HfBn2Cl2(Et2O)2 (1.80 g,
8 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins